Polyclonal Rabbit anti‑Human GABARAPL2 / ATG8 Antibody (aa1‑28, WB) LS‑C166387
Polyclonal Rabbit anti‑Human GABARAPL2 / ATG8 Antibody (aa1‑28, WB) LS‑C166387
Antibody:
GABARAPL2 / ATG8 Rabbit anti-Human Polyclonal (aa1-28) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
GABARAPL2 / ATG8 Rabbit anti-Human Polyclonal (aa1-28) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
ATG8 antibody LS-C166387 is an unconjugated rabbit polyclonal antibody to ATG8 (GABARAPL2) (aa1-28) from human. It is reactive with human and mouse. Validated for WB.
Target
Human GABARAPL2 / ATG8
Synonyms
GABARAPL2 | ATG8 | ATG8C | GEF2 | FLC3A | GATE-16 | GATE16 | GEF-2
Reactivity
Human, Mouse
(tested or 100% immunogen sequence identity)
Predicted
Rat, Cow (at least 90% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Protein A purified
Specificity
This GATE16 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-28 amino acids from the N-terminal region of human GATE16.
Presentation
PBS, 0.09% Sodium Azide
Storage
Maintain refrigerated at 2°C to 8°C for up to 6 months. For long term storage store at -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot, Flow Cytometry
Species:
Human, Mouse, Rat
Applications:
IHC - Paraffin, ICC, Immunofluorescence, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, ELISA
Species:
Human
Applications:
IHC, Western blot, Flow Cytometry, ELISA
Species:
Human, Mouse, Rat
Applications:
IHC, Immunofluorescence, Western blot
Reactivity:
Human
Range:
3.125-800 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/26/2024